Tag Archives: Drug

Lilly price break reverses NICE’s 'No' ruling on breast cancer drug Verzenio

Last October, England’s drug-cost watchdogs dealt Eli Lilly a blow when they decreed that the company’s CDK 4/6 inhibitor to treat breast cancer, Verzenio, wasn’t cost-effective. So Lilly dished up a new price break—and now the National Institute for Health and Care Excellence (NICE) is on board. The problem, initially, was that Lilly couldn’t provide evidence that Verzenio… Read More »

Viewpoints: The FDA Isn’t Up To The Task Of Reining In The Opioid Epidemic; The Downside Of Taking Children From Parents In Drug Treatment

Editorial writers weigh in on these and other health care topics. The Washington Post: This Is Why The Federal Government Has A Hard Time Regulating Prescription Opioids This past week, President Trump argued on national television that to end the opioid epidemic, Congress needed to fund the building of a wall at the United States’… Read More »

Trial for HIV prevention drug could DOUBLE

Trial for HIV prevention drug PrEP could DOUBLE after warnings hundreds of gay and bisexual men face being turned away from accessing the ‘game-changing’ pill Currently, pre-exposure prophylaxis (PrEP) is only available on a trial in England However, NHS England has today backed calls for the PrEP trial to double in size This would allow… Read More »